Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma
Clinical trial NCT02423837 · UNKNOWN
Trial details
- NCT number
- NCT02423837
- Sponsor
- National Research Center for Hematology, Russia
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.